Clinical Trials Browser

Phase 2 × elagolix × Clear all

NCT03951077 2022-06-08

Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome

Phase 2 Completed

118 enrolled 13 charts

Polycystic Ovary Syndrome

NCT01817530 2020-07-21

Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)

Phase 2 Completed

571 enrolled 32 charts

Leiomyoma, Menorrhagia